Target- |
MechanismImmunostimulants |
|
|
|
Inactive Indication- |
Drug Highest PhaseEarly Phase 1 |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Beijing Immupeutics Medicine Technology Co., Ltd.
0 Patents (Medical) associated with Beijing Immupeutics Medicine Technology Co., Ltd.
100 Deals associated with Beijing Immupeutics Medicine Technology Co., Ltd.
100 Translational Medicine associated with Beijing Immupeutics Medicine Technology Co., Ltd.